Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
about
Living proof and the pseudoscience of alternative cancer treatmentsNonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.Cure of multiple myeloma -- more hype, less reality.Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
P2860
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Long-term results (12 years) o ...... with de novo multiple myeloma.
@en
type
label
Long-term results (12 years) o ...... with de novo multiple myeloma.
@en
prefLabel
Long-term results (12 years) o ...... with de novo multiple myeloma.
@en
P2093
P356
P1433
P1476
Long-term results (12 years) o ...... with de novo multiple myeloma
@en
P2093
Bataille R
Harousseau JL
Morineau N
P2888
P304
P356
10.1038/SJ.LEU.2402613
P577
2002-09-01T00:00:00Z